Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesEndocrine, Nutritional and Metabolic Diseases and DisordersDRG 624-skin-grafts-and-wound-debridement-for-endocrine-nutritional-and-metabolic-disorders-without-cc-mcc
    Ask Trek AI about this page

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

    DRG 624 addresses inpatient stays for skin grafting and wound debridement tied to endocrine, nutritional, and metabolic disorders without Complication or Comorbidity or Major Complication or Comorbidity. It defines a mid-level payment category for Medicare by grouping surgical wound procedures in medically complex patients without additional coded complications, which affects reimbursement and billing classification.

    Customize your policy alerts

    Sign up for drg 624 policy alerts

    Get alerted when payer policies referencing 624 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 624 Overview

    DRG 624 covers inpatient stays for patients receiving skin grafts and wound debridement associated with endocrine, nutritional, and metabolic disorders when no Complication or Comorbidity or Major Complication or Comorbidity is present. Typical clinical cases include surgical management of noninfected chronic wounds or ulcers related to diabetes, malnutrition, or metabolic derangements without additional coded complications. This Diagnosis-Related Group matters for Medicare payment because it groups resource use for surgical wound procedures in a population with underlying metabolic conditions, influencing payment relative to more complex or uncomplicated wound care DRGs. Accurate coding of the primary procedure and the absence of Complication or Comorbidity or Major Complication or Comorbidity are central to correct reimbursement placement.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute surgical intervention trials evaluating techniques and perioperative protocols for skin grafting and wound debridement in patients hospitalized with endocrine, nutritional, or metabolic disorders (for example, severe diabetic foot infections or non-healing ulcers related to diabetic neuropathy). These studies focus on intraoperative variables (graft type, excision margins, negative-pressure therapy adjuncts) and immediate perioperative management to reduce operative time, infection rates, and need for reoperation. Results inform hospital resource use, length of stay, and short-term complication rates that directly affect DRG payments and inpatient care pathways.
    • Comparative effectiveness studies assessing different wound-care strategies and timing of reconstructive procedures in medically complex patients without major complications or comorbid conditions (the DRG excludes CC/MCC). These trials compare outcomes such as graft take, wound closure time, readmission, and need for additional debridement across interventions like split-thickness grafts versus local flap coverage, and conservative versus early surgical approaches in patients with metabolic disorders (eg, poorly controlled diabetes or malnutrition). Findings guide clinical decision-making and utilization management by identifying approaches that optimize clinical outcomes while minimizing additional inpatient days and downstream costs for payers and hospitals.
    • Post-discharge outcomes and care-coordination studies examining rehabilitation, wound-care follow-up, and prevention of recurrence in patients discharged after grafting/debridement for metabolic-related wounds. These prospective observational or pragmatic trials evaluate outpatient dressing protocols, home health engagement, glycemic and nutritional optimization, and rates of delayed complications or readmission within 30–90 days. This research is relevant to providers and payers because improved post-discharge management can reduce readmissions, lower total episode costs, and influence bundled payment performance metrics tied to DRG-based reimbursement.

    Related Codes

    614-ADRENAL-AND-PITUITARY-PROCEDURES-WITH-CC-MCC

    Adrenal and Pituitary Procedures with CC/MCC: Inpatient Reimbursement Overview

    615-ADRENAL-AND-PITUITARY-PROCEDURES-WITHOUT-CC-MCC

    Adrenal and Pituitary Procedures without CC/MCC: Inpatient Reimbursement Overview

    616-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    617-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    618-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITHOUT-CC-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

    619-O-R-PROCEDURES-FOR-OBESITY-WITH-MCC

    O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview

    620-O-R-PROCEDURES-FOR-OBESITY-WITH-CC

    O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

    621-O-R-PROCEDURES-FOR-OBESITY-WITHOUT-CC-MCC

    O.R. Procedures for Obesity without CC/MCC: Inpatient Reimbursement Overview

    622-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    623-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 25

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.